Immunogenicity and safety of Haemophilus influenzae type b polysaccharide-Neisseria meningitidis conjugate vaccine in 7.5 μg liquid formulation: A comparison of three lots with the 15.0 μg lyophilized formulation

Vaccine

Volumn 15, Issue 6-7, 1997, Pages 775-781

  Mendelman, Paul M ^a   Feeley, Louisa ^a   Bird, Steven ^a   Staub, Ted ^a   Matthews, Holly ^a   Del Beccaro, Mark A ^b   Overturf, Gary ^c   Lee, Ann ^a   Ellis, Ronald ^a   Staub, Joan ^a   Szymanski, Sally ^a   Donnelly, John ^a   Hennessey, John P ^a   Kniskern, Peter ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF NEW MEXICO HOSPITAL   (United States)

Author keywords

formulation; Haemophilus influenzae type b conjugate vaccine; PRP OMPC

Indexed keywords

HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE NEISSERIA MENINGITIDIS CONJUGATE VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; UNCLASSIFIED DRUG;

ANTIBODY TITER; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SAFETY; HUMAN; HUMAN EXPERIMENT; IMMUNE RESPONSE; IMMUNOGENICITY; INFANT; MULTICENTER STUDY; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RANDOMIZED CONTROLLED TRIAL; SEROLOGY; SINGLE BLIND PROCEDURE; VACCINATION;

BACTERIAL OUTER MEMBRANE PROTEINS; DOSAGE FORMS; DOSE-RESPONSE RELATIONSHIP, DRUG; FREEZE DRYING; HAEMOPHILUS VACCINES; HUMANS; INFANT; NEISSERIA MENINGITIDIS; POLYSACCHARIDES, BACTERIAL; SINGLE-BLIND METHOD; VACCINES, CONJUGATE;

EID: 8244240435     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(96)00129-6     Document Type: Article

References (24)

1. Centers for Disease Control and Prevention. Progress toward elimination of Haemophilus influenzae type b disease among infants and children - United States, 1987-1993. Morbid. Mortal. Wkly. Rep. 1994, 43, 144-148
2. Murphy, T.V., White, K.E., Pastor, P. et al. Declining incidence of Haemophilus influenzae type b disease since introduction of vaccination. J. Am. Med. Assoc. 1993, 269, 246-248
3. Adams, W.G., Deaver, K.A., Cochi, S.L. et al. Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. J. Am. Med. Assoc. 1993, 269, 221-226
4. Broadhurst, L.E., Erickson, R.L. and Kelley, P.W. Decreases in invasive Haemophilus influenzae diseases in US Army children, 1984 through 1991. J. Am. Med. Assoc. 1993, 269, 227-231
5. Schoendorf, K.C., Adams, W.G., Kiely, J.L. and Wenger, J.D. National trends in Haemophilus influenzae meningitis mortality and hospitalization among children, 1980 through 1991. Pediatrics 1994, 93, 663-668
6. Centers, for Disease Control and Prevention. Reported vaccine-preventable diseases - United States, 1993, and the Childhood Immunization Initiative. Morbid. Mortal. Wkly. Rep. 1994, 43, 57-60
7. Santosham, M., Hill, J., Wolff, M., Reid, R., Lukacs, L. and Ahonkhai, V. Safety and immunogenicity of Haemophilus influenzae type b conjugate vaccine in a high risk American Indian population. Pediatr. Infect. Dis. J. 1991, 10, 113-117
8. Santosham, M., Rivin, B., Wolff, M. et al. Prevention of Haemophilus influenzae type b infections in Apache and Navajo children. J. Infect. Dis. 1992, 165, S144-S151
9. Santosham, M., Wolff, M., Reid, R. et al. The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex. N. Engl. J. Med. 1991, 324, 1767-1772
10. Harrison, L.H., Tajtowski, C., Croll, J. et al. Postlicensure effectiveness of the Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer-membrane protein complex conjugate vaccine among Navajo children. J. Pediatr. 1994, 125, 571-576
11. Ahonkhai, V.I., Lukacs, L.J., Jonas, L.C. and Calandra, G.B. Clinical experience with PedvaxHIB, a conjugate vaccine of Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein. Vaccine 1991, 9, S38-S41
12. Calandra, G.B., Lukacs, L.J., Jonas, L.C. et al. Anti-PRP antibody levels after a primary series of PRP-OMPC and persistence of antibody titers following primary booster doses. Vaccine 1993, 11, S58-S62
13. Shehab, Z.M., Azimi, P., Asmar, B.I., Dunphy, M.G., Ayoub, E.M. and Dajani, A.S. Immunogenicity and reactogenicity of Haemophilus influenzae type b-meningococcus group b outer membrane protein conjugate vaccine in children 2-60 months of age. Scand. J. Infect. Dis. 1991, 23, 763-769
14. Ambrosino, D.M., Sood, S.K., Lee, M.C. et al. lgG1, lgG2 and lgM responses to two Haemophilus influenzae type b conjugate vaccines, in young infants. Pediatr. Infect. Dis. J. 1992, 11, 855-859
15. Decker, M.D., Edwards, K.M., Bradley, R. and Palmer, P. Comparative trial in infants of four conjugate Haemophilus influenzae type b vaccines. J. Pediatr. 1992, 120, 184-189
16. Granoff, D.M., Anderson, E.L., Osterholm, M.T. et al. Differences in the immunogenicity of three Haemophilus influenzae type b conjugate vaccines in infants. J. Pediatr. 1992, 121, 187-194
17. Granoff, D.M. and Holmes, S.J. Comparative immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugate vaccines. Vaccine 1991, 9, S30-S34
18. Wong, V.K., Quagliata, R., Adler, R. and Kim, K.S. Dose-related immunogenicity of Haemophilus influenzae type b capsular polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine. Am. J. Dis. Child. 1991, 145, 742-745
19. Kennedy, D.J. and Anderson, E.L. Immunogenicity of a 1 mcg liquid formulation of PedvaxHIB(R). Infectious Diseases Society of America (IDSA) 33rd Annual Meeting, San Francisco, 1995, p. 115
20. Vella, P.P. and Ellis, R.W. Haemophilus B conjugate vaccines. In: Vaccines: New Approaches to Immunological Problems (Ed. Ellis, R.W). Butterworth-Heinemann, Boston, 1992, pp. 2-22
21. Robbins, J.B., Schneerson, R. and Parke, J.C. A review of efficacy trials with H. influenzae type b polysaccharide vaccines. In: Haemophilus Influenzae, Epidemiology, Immunology, and Prevention of Disease (Eds Sell, S.H. and Wright, P.F.). Elsevier Biomedical, New York, 1982, pp. 255-263
22. Kayhty, H., Peltola, H., Karanko, V. and Makela, P.H. The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b. J. Infect. Dis. 1983, 147, 1100
23. Granoff, D.M., Holmes, S.J., Osterholm, M.T. et al. Induction of immunologic memory in infants primed with Haemophilus influenzae type b conjugate vaccines. J. Infect. Dis. 1993, 168, 663-671
24. Committee on Infectious Diseases. Red Book. American Academy of Pediatrics, Elk Grove, IL, 1994